Dr. Robert Albert Anders is an associate professor of pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. His clinical expertise includes pathology.
Dr. Anders received his M.D. from Mayo Clinic Medical School College of Medicine. He completed his residency in anatomic and clinical pathology and a fellowship in pathology from the University of Chicago Hospitals.
His research interests include gastrointestinal and liver pathology.
Selected Publications
- Adler nd immunophenotypic featuBL, ..., Voltaggio L, ..., Taube JM, Anders RA. Histopathological ares of ipilimumab-associated colitis compared to ulcerative colitis. J Intern Med. 2018 Jun;283(6):568-77
- Chianchiano P,..., Voltaggio L, Oshima K, Anders RA, Wood LD. Distinction of Intrahepatic Metastasis from Multicentric Carcinogenesis in Multifocal Hepatocellular Carcinoma Using Molecular Alterations. Hum Pathol 2018 Feb;72:127-34.
- Monaco DR, Kottapalli SV, Breitwieser FP, Anderson DE, Wijaya L, Tan K, Chia WN, Kammers K, Caturegli P, ..., Wang LF, Larman HB. Deconvoluting virome-wide antibody epitope reactivity profiles. EBioMedicine 2021 Dec ;75:103747
- Waters KM, Cottrell TR, Besharati S, Zhu Q, Anders RA. Evaluation of Peritumoral Fibrosis in Metastatic Colorectal Adenocarcinoma to the Liver Using Digital Image Analysis. Am J Clin Pathol 2019 Jan;151(2):226-30.
- Sagara T, Debeljak M, Wright CM, Anders NM, Liang H, Rudek MA, Ostermeier M, Eshleman JR*, Matsushita Y. Successful gene therapy requires targeting the vast majority of cancer cells. Cancer Biol Ther 2020 Oct;21(10):946-53
- Bracamonte-Baran W, Gilotra NA, ..., Anders RA, Zhu Q, Halushka MK, Brandacher G, Čiháková D. Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8+ T-Cell Infiltration After Heart Transplantation. Circ Heart Fail 2021 Oct;14(10):e007982
- Argani P, ..., Anders RA, ..., Kwon R, Voltaggio L,..., Oshima K, Rooper L, Matoso A, ..., Antonescu CR. A Novel NIPBL-NACC1 Gene Fusion is Chrctristc of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma. Am J Surg Pathol 2021 Nov;45(11):1550-60
- Debeljak M, Noë M, Riel SL, Haley LM, Norris AL, Anderson DA, Adams EM, Suenaga M, Beierl KF, Lin MT, Goggins MG, Gocke CD, Eshleman JR. Validation Strategy for Ultrasensitive Mutation Detection. Mol Diagn Ther. 2018 Oct;22(5):603-11.
- Stein JE, Lipson EJ, Cottrell TR, Forde PM, Anders RA, Cimino-Mathews A, Thompson ED, …, Jaffee EM, Pardoll DM, Topalian SL, Taube JM. Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade. Clin Cancer Res 2020 Feb;26(3):545-51
- Taube JM, Galon J, Sholl LM, Rodig SJ, Cottrell TR, Giraldo NA, Baras AS, Patel SS, Anders RA, Rimm DL, Cimino-Mathews A. Implications of the tumor immune microenvironment for staging and therapeutics. Mod Pathol. 2018 Feb;31(2):214-34.